KRAS Clinical Trials

SPARK study: Studying Pathways of Resistance in KRAS-driven Cancers

Brief Summary “Up to 250 patients from anywhere in the United States can remotely consent and participate to have plasma drawn locally...

Oct 13, 20241 min read

Rev Med reports out on the 46% of the pancreatic cancer patients who were enrolled in NCT05379985 (54% of patients are NSLC or other...

Jul 24, 20241 min read

Kristi shares with others about her KRAS lung cancer diagnosis and experience with clinical trials.

Sep 16, 20224 min read

ESMO24 abstract 608O - Preliminary safety and clinical activity of ASP3082, a first-in-class, KRAS G12D selective protein degrader in...

Upstage Lung Cancer heard the power of hope to kick cancer from Terri Conneran

Brief Summary “Up to 250 patients from anywhere in the United States can remotely consent and participate to have plasma drawn locally...